M. Ono, Naoko Ohno, K. Hasegawa, Shigeo Tanaka, M. Komiya, H. Matsumoto, A. Fujii, Y. Akimoto
{"title":"钙通道阻滞剂引起牙龈过度生长的发生率","authors":"M. Ono, Naoko Ohno, K. Hasegawa, Shigeo Tanaka, M. Komiya, H. Matsumoto, A. Fujii, Y. Akimoto","doi":"10.11263/JSOTP1982.27.79","DOIUrl":null,"url":null,"abstract":"The incidence of gingival overgrowth caused by calcium channel blockers was determined. The overgrowth was found in patients receiving amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine. The highest rate of gingival overgrowth was obtained by nifedipine (7.6%), followed by diltiazem (4.1%), manidipine (1.8%), amlodipine (1.l%), nisoldipine (1.1%) and nicardipine (0.5%). The rate of nifedipine-induced gingival overgrowth was significantly higher than those of amlodipine, manidipine, nicardipine and nisoldipine, but not diltiazem.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"79-85"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.11263/JSOTP1982.27.79","citationCount":"9","resultStr":"{\"title\":\"Incidence of gingival overgrowth caused by calcium channel blockers\",\"authors\":\"M. Ono, Naoko Ohno, K. Hasegawa, Shigeo Tanaka, M. Komiya, H. Matsumoto, A. Fujii, Y. Akimoto\",\"doi\":\"10.11263/JSOTP1982.27.79\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The incidence of gingival overgrowth caused by calcium channel blockers was determined. The overgrowth was found in patients receiving amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine. The highest rate of gingival overgrowth was obtained by nifedipine (7.6%), followed by diltiazem (4.1%), manidipine (1.8%), amlodipine (1.l%), nisoldipine (1.1%) and nicardipine (0.5%). The rate of nifedipine-induced gingival overgrowth was significantly higher than those of amlodipine, manidipine, nicardipine and nisoldipine, but not diltiazem.\",\"PeriodicalId\":19590,\"journal\":{\"name\":\"Oral Therapeutics and Pharmacology\",\"volume\":\"27 1\",\"pages\":\"79-85\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.11263/JSOTP1982.27.79\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Therapeutics and Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11263/JSOTP1982.27.79\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Therapeutics and Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11263/JSOTP1982.27.79","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Incidence of gingival overgrowth caused by calcium channel blockers
The incidence of gingival overgrowth caused by calcium channel blockers was determined. The overgrowth was found in patients receiving amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine. The highest rate of gingival overgrowth was obtained by nifedipine (7.6%), followed by diltiazem (4.1%), manidipine (1.8%), amlodipine (1.l%), nisoldipine (1.1%) and nicardipine (0.5%). The rate of nifedipine-induced gingival overgrowth was significantly higher than those of amlodipine, manidipine, nicardipine and nisoldipine, but not diltiazem.